MedTrace Logo

Cellular and Humoral Immunity in Elderly After Immunization With a Japanese Encephalitis Vaccine

NCT01398540 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-03-29

No results posted yet for this study

Summary

The aim of this project is to investigate humoral and cellular immune responses before and after immunisation with the Japanese encephalitis vaccine IXIARO in subjects above 60 years of age and 18-40 years old subjects.

Conditions

  • Humoral and Cellular Immune Responses

Interventions

BIOLOGICAL

IXIARO

2 immunizations (0,5ml) with a 28 day interval

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Ursula Wiedermann, MD, PhD · Institute of Specific Prophylaxis and Tropical medicine, Vienna

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2012-10-31
Completion
2013-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01398540 on ClinicalTrials.gov